Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Blood|February 28, 2002
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patientsJohn M Timmerman, Debra K Czerwinski, Thomas A Davis, et al.
Scientific Reports|February 4, 2018
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linkingAnna H Turaj, Kerry L Cox, Christine A Penfold, et al.
The American Journal of Pathology|August 21, 2012
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implicationsMatthew W Anderson, Shuchun Zhao, Aharon G Freud, et al.
Blood|November 3, 2011
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 studyYoun H Kim, Dita Gratzinger, Cameron Harrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2020
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20<sup>+</sup> Non-Hodgkin LymphomasAjay K Gopal, Ronald Levy, Roch Houot, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentationMichael R Green, Shingo Kihira, Chih Long Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2025
Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imagingNisi Zhang, Jai Woong Seo, Elise Robinson, et al.
Blood|December 8, 2009
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemiaJonathan W Friedberg, Jeff Sharman, John Sweetenham, et al.
American Journal of Hematology|February 14, 2020
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphomaJohn Timmerman, Charles Herbaux, Vincent Ribrag, et al.
Blood Advances|November 8, 2023
A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysisTanaya Shree, Sarah Haebe, Debra K Czerwinski, et al.
Pageof 17